The success of Viagra initially drove a boom for pharma, however recent changes present a uncertain picture for shareholders. Generic versions are eroding revenue, and persistent legal battles add additional risk to https://minarywm673574.dgbloggers.com/41605743/sildenafil-and-the-pharmaceutical-industry-a-risky-play